Hospira - Endotool® Glucose Management System

Paper protocols use simple, two point linear mathematics
EndoTool uses four data points to compute each patient's unique physiologic dose of insulin
The average time to control a patient is between 5 to 6 hours
Over 67% of all blood glucose readings after 4 hours using EndoTool-guided insulin dosing have been between 70-120 mg/dL
The average of all readings after 4 hours using EndoTool is 116 mg/dL

Goal ranges can be set by unit throughout your hospital to adapt to different patient needs
Audible alarms remind the staff when a glucose value is due
Subcutaneous transition orders use your preferred long and short acting insulins
Fully HIPAA compliant
Prints medication administration records and QA reports
Allows you to use the same standard of glycemic control throughout your hospital

EndoTool requires a few simple inputs to set up a patient. After that, all that is needed is the patient's blood glucose level from a point-of-care device to be entered into the software
EndoTool eliminates paper protocols and "bedside" math
EndoTool will switch to Q2 hour dosing up to 40% of the time, with a Q3 hour option available
EndoTool can accept ADT (Admit, Discharge and Transfer) feeds directly from your HIS system to make setting up a patient even quicker. Outbound HL7 messaging allows you to direct EndoTool to put the data where you need it
Bar code scanning capability for medication and patient verification is also available
Effective for challenging patients, such as Diabetic Ketoacidosis (DKA), Hyperglycemic Hyperosmolar Nonketotic Coma (HHNK) and transplant patients

Uses multiple data points to model each individual patient's unique physiologic insulin dose
Automatically determines the time for the next blood glucose check
Can print patient-specific subcutaneous insulin transition orders

In a head-to-head comparison of EndoTool with a standard paper-based protocol, EndoTool was more effective at keeping patients in the goal range.² The results had a p<0.0001, which is highly statistically significant

With EndoTool's sophisticated control mathematics, the incidence of hypoglycemia is extremely low, <0.05% of readings¹
This rate is significantly lower than published studies by Van den Berghe^3,4 Brunkhorst⁵ and others

Patients can be set up quickly and easily, especially with the optional ADT feed
"Bedside math" or picking between columns, as with many paper protocols, is eliminated — a simple blood glucose level is all that is needed
Allows a hospital to set one standard of glycemic care throughout the hospital, from the OR, to the ICUs to the floor
The need to check a patient's blood glucose level which shift to Q2 about 40% of the time. A Q3 hour option is also available

Comprehensive initial evaluation of current hospital policies and procedures by our experienced critical care nursing staff to define current practice patterns
Examples of glycemic control "best practices" from AACN, ACE, and ADA are discussed and shared
Thorough "Go Live" schedule developed for each individual hospital to keep key audiences (nursing, physicians and pharmacy) informed and up-to-date
In-depth on-site training provided by our experienced critical care nursing staff
Hospira goal is to train 90% of the hospital employees who will be using of EndoTool

Toll-free clinical and product support phone number will be routed to a clinical specialist with clinical EndoTool experience
IT support also available via the same toll-free phone number

References

Data on file. Incidence of hypoglycemia (≤40 mg/dL). Goal range was set to 85-120 mg/dL. Hospira, Inc.
Saager L, et al. J of Cardiothoracic & Vasc Anesth 2008; 22:377-382.
Van en Berghe G, et al. N Engl J Med 2001; 345:1359-67
Van den Berghe G, et al. N Engl J Med 2006; 354:449-61.
Brunkhorst FM, et at. N Engl J Med 2008;358:125-139.